1-3 of 3
Gillian F. Cropp
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Clinical Trial of the Novel Structure Proteasome Inhibitor NPI-0052 in Patients with Relapsed and Relapsed/Refractory Multiple Myeloma (MM).

Free
Paul Richardson, M.D, Craig Hofmeister, MD, Andrzej Jakubowiak, MD, PhD, Todd M. Zimmerman, MD, Matthew A. Spear, MD, Michael A. Palladino, PhD, Angie M. Longenecker, RN, BSN, Susan L. Kelly, MD, Saskia Neuteboom, PhD, Gillian F Cropp, MSc, G. Kenneth Lloyd, PhD, Alison L. Hannah, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 431.
https://doi.org/10.1182/blood.V114.22.431.431
Published: 2009
Journal Articles

Phase 1 Clinical Trial of a Novel Proteasome Inhibitor (NPI-0052) in Patients with Lymphomas and Solid Tumors.

Free
Razelle Kurzrock, MD, Paul Hamlin, M.D., Anas Younes, M.D., David Hong, M.D., Michael Gordon, M.D., Matthew A. Spear, M.D., Michael A. Palladino, Ph.D., G. Kenneth Lloyd, Ph.D., Angie M. Longenecker, R.N., Saskia T.C. Neuteboom, Ph.D., Gillian F. Cropp, M.S., Alison Hannah, M.D., Carol Aghajanian, M.D.
Journal: Blood
Blood (2007) 110 (11): 4504.
https://doi.org/10.1182/blood.V110.11.4504.4504
Published: 2007
Journal Articles

Safety and Activity of KOS-953 in Patients with Relapsed Refractory Multiple Myeloma (MM): Interim Results of a Phase 1 Trial.

Free
Paul G. Richardson, MD, Asher A. Chanan-Khan, MD, Melissa Alsina, MD, Deborah Doss, R.N., Beverly Landrigan, R.N., Dawn Kettner, N.P., Maher Albitar, MD, Constantine Mitsiades, MD, Gillian F. Cropp, MS, Robert G. Johnson, MD, Alison L. Hannah, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2005) 106 (11): 361.
https://doi.org/10.1182/blood.V106.11.361.361
Published: 2005